LI, Chengtai. Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis. MedScien, [S. l.], v. 4, n. 1, p. 6812, 2026. DOI: 10.61173/as39n470. Disponível em: https://ms.deanfrancis.press/article/view/28. Acesso em: 23 oct. 2026.